Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
about
AAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsChemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.Chemotherapy-Induced Neuropathy in Cancer Survivors.Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: protocol for a systematic review and meta-analysis.Bilateral blindness with secondary retinitis pigmentosa following postoperative docetaxel and platinum combination chemotherapy in primary small-cell carcinoma of the endometrium: An unusual case report and review of the literature.Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall riskThe early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.Living with chronic pain: perceptions of breast cancer survivors.Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx®): a placebo-controlled randomised phase II study (PLIANT).Incidence and disease burden of chemotherapy-induced peripheral neuropathy in a population-based cohort.Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study.Potential Benefits of Annona muricata in Combating Cancer: A Review.Chemotherapy-induced peripheral neuropathy: evidence from genome-wide association studies and replication within multiple myeloma patients
P2860
Q28079708-82B2B15E-6F1E-4256-B466-F27BDE05E970Q38664595-EBBE276A-1B68-4D2A-AD76-0850254ECDC3Q38773529-01AC130A-473F-4CDC-9360-8FA1EB7F6979Q39021089-7BC60170-3EF9-4207-9AA1-81858C9EFBE1Q39245520-E1F11381-3AB2-46EF-831C-789CF807B5C1Q41009010-0FF10AC6-7C49-4FF1-8CF3-D1F61D9D3C24Q41227394-EB24FE03-3228-47F3-8DD4-5A014BB4C5C5Q46606896-FAF67F69-4109-4496-9387-33598940A092Q47767827-5F4134D6-1279-4139-9F49-ECF364F3F5E9Q47979421-C6FBADF3-CF73-403C-A8B5-3F7B96C65CD3Q48209604-A51379ED-098B-45EE-BB5A-3653D73776CFQ50002199-BF7C75E1-8F96-40C5-A311-E5A591A53AA9Q50035155-38FF4F7B-2E5A-4AA7-B875-26E1CEF74A96Q50089791-1770D711-4A22-47C4-A656-F7A584381914Q51436755-F636D446-92CD-48E0-91EF-7358C40A73E0Q53078776-75BB958B-D64B-4093-9F94-38C57B7B239AQ55005473-9A056EC8-4BAE-4D48-B632-BC91D17E067DQ58778223-8D00472C-5243-4E72-AEDB-B2D0CA4F2065
P2860
Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@en
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@nl
type
label
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@en
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@nl
prefLabel
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@en
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@nl
P2093
P2860
P356
P1476
Comorbidities and Risk of Chem ...... ncology Group Clinical Trials.
@en
P2093
Cathee Till
Danielle Awad
Jason D Wright
Joseph Unger
Lori M Minasian
Scott D Ramsey
William E Barlow
P2860
P304
P356
10.1200/JCO.2015.66.2346
P407
P577
2016-06-20T00:00:00Z